These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 34105901)
1. A systematic review of myasthenia gravis complicated with myocarditis. Cheng W; Sun T; Liu C; Zhou Z; Duan J; Zhao Y; Yang M; Chen P Brain Behav; 2021 Aug; 11(8):e2242. PubMed ID: 34105901 [TBL] [Abstract][Full Text] [Related]
2. Immune Checkpoint Inhibitor-Induced Myocarditis with Myositis/Myasthenia Gravis Overlap Syndrome: A Systematic Review of Cases. Pathak R; Katel A; Massarelli E; Villaflor VM; Sun V; Salgia R Oncologist; 2021 Dec; 26(12):1052-1061. PubMed ID: 34378270 [TBL] [Abstract][Full Text] [Related]
3. Improved outcomes with early immunosuppression in patients with immune-checkpoint inhibitor induced myasthenia gravis, myocarditis and myositis: a case series. Weaver JM; Dodd K; Knight T; Chaudhri M; Khera R; Lilleker JB; Roberts M; Lorigan P; Cooksley T Support Care Cancer; 2023 Aug; 31(9):518. PubMed ID: 37572133 [TBL] [Abstract][Full Text] [Related]
4. Characterization of Immune Checkpoint Inhibitor-Induced Myasthenia Gravis Using the US Food and Drug Administration Adverse Event Reporting System. Niimura T; Zamami Y; Miyata K; Mikami T; Asada M; Fukushima K; Yoshino M; Mitsuboshi S; Okada N; Hamano H; Sakurada T; Matsuoka-Ando R; Aizawa F; Yagi K; Goda M; Chuma M; Koyama T; Izawa-Ishizawa Y; Yanagawa H; Fujino H; Yamanishi Y; Ishizawa K J Clin Pharmacol; 2023 Apr; 63(4):473-479. PubMed ID: 36453166 [TBL] [Abstract][Full Text] [Related]
12. A case report and literature review on respiratory failure with immune checkpoint inhibitors: a life-threatening adverse event. Lin X; Guan W; Li B; Deng H; Chen Y; Yang Y; Qiu G; Xie X; Zhou C Immunopharmacol Immunotoxicol; 2023 Dec; 45(6):780-787. PubMed ID: 37339370 [TBL] [Abstract][Full Text] [Related]
13. Immune checkpoint inhibitor-induced myocarditis with myasthenia gravis overlap syndrome: A case report and literature review. Gao L; Li X; Guo Z; Tang L; Peng J; Liu B Medicine (Baltimore); 2022 Dec; 101(49):e32240. PubMed ID: 36626474 [TBL] [Abstract][Full Text] [Related]
14. Consider Myocarditis When Patients Treated with Immune Checkpoint Inhibitors Present with Ocular Symptoms. Rhee JY; Torun N; Neilan TG; Guidon AC Oncologist; 2022 May; 27(5):e402-e405. PubMed ID: 35348772 [TBL] [Abstract][Full Text] [Related]
15. Durvalumab-induced myocarditis, myositis, and myasthenia gravis: a case report. Cham J; Ng D; Nicholson L J Med Case Rep; 2021 May; 15(1):278. PubMed ID: 34053457 [TBL] [Abstract][Full Text] [Related]
16. Inflammatory Myositis in Cancer Patients Receiving Immune Checkpoint Inhibitors. Aldrich J; Pundole X; Tummala S; Palaskas N; Andersen CR; Shoukier M; Abdel-Wahab N; Deswal A; Suarez-Almazor ME Arthritis Rheumatol; 2021 May; 73(5):866-874. PubMed ID: 33258544 [TBL] [Abstract][Full Text] [Related]
17. Coexisting of myasthenia gravis and fulminant myocarditis induced by nivolumab in a patient with ureteral epithelial cancer. Zhang J; Li J; Zhai L; Lin L Neuro Endocrinol Lett; 2021 Oct; 42(6):383-386. PubMed ID: 34713689 [TBL] [Abstract][Full Text] [Related]
18. Immune Checkpoint Inhibitor-Induced Myocarditis With Concurrent Myasthenia Gravis. Kuniyoshi J; Huang R; Choi H; Bernas M; Techasatian W; Nishimura Y Can J Cardiol; 2023 Nov; 39(11):1646-1648. PubMed ID: 37330137 [No Abstract] [Full Text] [Related]
19. Myocarditis related to immune checkpoint inhibitors treatment: two case reports and literature review. Chen Y; Jia Y; Liu Q; Shen Y; Zhu H; Dong X; Huang J; Lu J; Yin Q Ann Palliat Med; 2021 Jul; 10(7):8512-8517. PubMed ID: 34263614 [TBL] [Abstract][Full Text] [Related]